Cargando…

Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction

Background: Heart failure (HF) is associated with type 2 diabetes mellitus (T2DM). Antihyperglycemic drugs have interaction with heart failure among diabetic patients. To date, the data on real world use of diabetic medication in Malaysian heart failure patients with T2DM has not been elucidated. Ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shu Ning, Phang, Kok Kit, Toh, Seng Hsiung, Chee, Kok Han, Zaman Huri, Hasniza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366349/ https://www.ncbi.nlm.nih.gov/pubmed/32754118 http://dx.doi.org/10.3389/fendo.2020.00448

Ejemplares similares

Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study
por: Yang, Chen Die, et al.
Publicado: (2023)

Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia
por: Zaman Huri, Hasniza, et al.
Publicado: (2013)

Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
por: Kirkman, Danielle L., et al.
Publicado: (2020)

Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction
por: Altara, Raffaele, et al.
Publicado: (2017)

Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction
por: Sickinghe, Ariane A., et al.
Publicado: (2019)

Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2015)

Weight cycling and risk of clinical adverse events in patients with heart failure with preserved ejection fraction: a post-hoc analysis of TOPCAT
por: Tan, Yi, et al.
Publicado: (2023)

Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review
por: Almualm, Yasmin, et al.
Publicado: (2015)

Drug-related problems in patients with rheumatoid arthritis
por: Ma, Shu Ning, et al.
Publicado: (2019)

Diabetes in Patients With Heart Failure With Reduced Ejection Fraction During Hospitalization: A Retrospective Observational Study
por: Zhou, Yiling, et al.
Publicado: (2021)

Anabolic Hormones Deficiencies in Heart Failure With Preserved Ejection Fraction: Prevalence and Impact on Antioxidants Levels and Myocardial Dysfunction
por: Bruno, Carmine, et al.
Publicado: (2020)

Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study
por: Zaman Huri, Hasniza, et al.
Publicado: (2013)

Serum uric acid: A risk factor for right ventricular dysfunction and prognosis in heart failure with preserved ejection fraction
por: Deng, Xiang-liang, et al.
Publicado: (2023)

Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Syed Ikmal, Sharifah Intan Qhadijah, et al.
Publicado: (2013)

Effects of sacubitril/valsartan on both metabolic parameters and insulin resistance in prediabetic non-obese patients with heart failure and reduced ejection fraction
por: Cloro, Cosima, et al.
Publicado: (2022)

Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2019)

Beyond Glycemic Control in Diabetes Mellitus: Effects of Incretin-Based Therapies on Bone Metabolism
por: Ceccarelli, Elena, et al.
Publicado: (2013)

Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial
por: Siriyotha, Sukanya, et al.
Publicado: (2023)

Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2017)

Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2016)

Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention
por: Mokhtar, Fadzlin Mohd, et al.
Publicado: (2021)

Tropical Plant Extracts as Potential Antihyperglycemic Agents
por: Manaharan, Thamilvaani, et al.
Publicado: (2012)

Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status
por: Jiang, Wangyan, et al.
Publicado: (2023)

Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
por: Dhore-patil, Aneesh, et al.
Publicado: (2022)

Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Retinol-Binding Protein-4—A Predictor of Insulin Resistance and the Severity of Coronary Artery Disease in Type 2 Diabetes Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2021)

Single Nucleotide Polymorphism rs17173608 in the Chemerin Encoding Gene: Is It a Predictor of Insulin Resistance and Severity of Coronary Artery Disease in Non-Obese Type 2 Diabetes?
por: Perumalsamy, Sangeetha, et al.
Publicado: (2021)

Comparing Different Diagnostic Guidelines for Gestational Diabetes Mellitus in Relation to Birthweight in Sri Lankan Women
por: Dias, Thiran, et al.
Publicado: (2018)

High Liver Enzyme Concentrations are Associated with Higher Glycemia, but not with Glycemic Variability, in Individuals without Diabetes Mellitus
por: Noordam, Raymond, et al.
Publicado: (2017)

Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period
por: Al-Mutairi, Abrar M., et al.
Publicado: (2023)

Management of Hypertensive Emergency in the Setting of Primary Aldosteronism Complicated by Heart Failure With Reduced Ejection Fraction
por: Sarguroh, Tauseef, et al.
Publicado: (2023)

Incretin-Based Antihyperglycemic Agents for the Management of Acute Ischemic Stroke in Patients with Diabetes Mellitus: A Review
por: Milonas, Dimitrios, et al.
Publicado: (2019)

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus
por: Nargesi, Arash A., et al.
Publicado: (2021)

Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2023)

Drug-related problems in patients with erectile dysfunctions and multiple comorbidities
por: Huri, Hasniza Zaman, et al.
Publicado: (2017)

Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k5laocf3oo9pau8tjn2dvvcmj7